Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A tumor mass composed of myeloblasts or immature myeloid cells. It occurs in extramedullary sites or the bone. (WHO, 2001)
Biomarker and diagnostic research for myeloid sarcoma has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
7 clinical trials registered, 4 recruiting. Interventions under study include drug therapy, biologic therapy, other interventions, and medical devices. Pipeline includes 1 PHASE3, 3 PHASE2, 2 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT04797767](https://clinicaltrials.gov/study/NCT04797767) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:53 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms |
PHASE1 |
University of Washington |
RECRUITING |
[NCT07028086](https://clinicaltrials.gov/study/NCT07028086) | VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma | PHASE2 | Ruijin Hospital | RECRUITING |
[NCT05735184](https://clinicaltrials.gov/study/NCT05735184) | A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML | PHASE1 | Kura Oncology, Inc. | RECRUITING |
[NCT02790515](https://clinicaltrials.gov/study/NCT02790515) | Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation | PHASE2 | St. Jude Children's Research Hospital | ACTIVE_NOT_RECRUITING |
[NCT06111612](https://clinicaltrials.gov/study/NCT06111612) | Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement | — | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | RECRUITING |
216 publications have been identified in PubMed for myeloid sarcoma. Research spans Case Report / Case Series (72%), Diagnostic / Biomarker (6%), and Review / Meta-Analysis (6%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 156 | 72% |
Testing and diagnosis research | 13 | 6% |
Research summaries | 13 | 6% |
Laboratory research | 13 | 6% |
Clinical study results | 8 | 4% |
Other research | 7 | 3% |
Disease patterns and progression | 6 | 3% |
Pustake M (2026). [PMID: 41910305](https://pubmed.ncbi.nlm.nih.gov/41910305/). *J Cancer Res Ther*. [Case Report / Case Series]
Christie-Nguyen B (2026). [PMID: 41963109](https://pubmed.ncbi.nlm.nih.gov/41963109/). *J Cutan Pathol*. [Case Report / Case Series]
Edrees R (2026). [PMID: 41760034](https://pubmed.ncbi.nlm.nih.gov/41760034/). *Medicine (Baltimore)*. [Case Report / Case Series]
Yong KY (2026). [PMID: 41814874](https://pubmed.ncbi.nlm.nih.gov/41814874/). *Cancer Rep (Hoboken)*. [Review / Meta-Analysis]
Nayak AR (2026). [PMID: 41522527](https://pubmed.ncbi.nlm.nih.gov/41522527/). *Indian J Hematol Blood Transfus*. [Other]
Yang JH (2026). [PMID: 41914421](https://pubmed.ncbi.nlm.nih.gov/41914421/). *Zhongguo Dang Dai Er Ke Za Zhi*. [Case Report / Case Series]
Robisco E (2026). [PMID: 41688254](https://pubmed.ncbi.nlm.nih.gov/41688254/). *Int J Gynecol Cancer*. [Case Report / Case Series]
Banzo Navascués M (2026). [PMID: 41550052](https://pubmed.ncbi.nlm.nih.gov/41550052/). *Cir Pediatr*. [Case Report / Case Series]
Parker JR (2026). [PMID: 41212680](https://pubmed.ncbi.nlm.nih.gov/41212680/). *Int J Surg Pathol*. [Case Report / Case Series]
Çetinarslan T (2026). [PMID: 41522545](https://pubmed.ncbi.nlm.nih.gov/41522545/). *Indian J Hematol Blood Transfus*. [Case Report / Case Series]
AI-curated news mentioning myeloid sarcoma
Updated Aug 13, 2026
A rare case report details isolated bilateral breast myeloid sarcoma, contributing to the understanding of this uncommon condition. This case adds to the limited literature on myeloid sarcoma presentations.
A case report details myeloid sarcoma of the septum pellucidum in an elderly woman, presenting with hallucinations and personality changes. This rare condition highlights the need for further research into its clinical manifestations and treatment options.
A case report highlights a rare instance of primary isolated lumbar spine myeloid sarcoma, contributing to the limited literature on this condition. The findings may inform future research and clinical approaches to similar rare cases.